2020
DOI: 10.1007/s10792-020-01634-8
View full text
|
|

Abstract: Purposes Retinal neurodegenerative diseases are responsible for a huge number of ocular problems worldwide. It seems that the progression of these diseases can be managed by the application of neuroprotective molecules particularly in the early stages. This article focuses on the most common neuroprotective bioagents under investigation in ophthalmology. Methods We searched the web of science, PubMed and Scopus databases with these keywords: ''glaucoma,'' ''diabetic retinopathy,'' ''age-related macular degener… Show more

Help me understand this page

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals